Topical NSAID Osteoarthritis Guidelines Need Revision, British Study Says
This article was originally published in The Tan Sheet
Executive Summary
Long-term use of topical nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis is not supported by trial data, according to a meta-analysis published in the British Medical Journal
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning